Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Veru
Veru
(VERU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sacituzumab
breast neoplasms
,
triple negative breast neoplasms
Enobosarm
obesity
,
breast neoplasms
Aglatimagene besadenovec
adenocarcinoma
,
obesity
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
Sabizabulin
breast neoplasms
,
respiratory distress syndrome
,
acute lung injury
,
newborn respiratory distress syndrome
,
syndrome
,
triple negative breast neoplasms
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
severe acute respiratory syndrome
,
covid-19
,
infections
Bevifimod
breast neoplasms
Enclomiphene
prostatic neoplasms
Viaject
obesity
Pd0332991
breast neoplasms
Androxal
prostatic neoplasms
Pcv
obesity
Ph3
breast neoplasms
Adt
prostatic neoplasms
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use